Beating-heart compatibility: Reduces stroke risks and complications, and potentially over 50% cost reduction with a standardized, reproducible and easy-to-learn technology. EDE/UTRECHT, The ...
AMT Medical B.V. rolls out Phase II of SAFE-CAB Trial to obtain CE mark of the Elana® Heart Bypass System. U.S. Early Feasibility Trial discussed with FDA. The Elana Heart Bypass System has great ...
AMT Medical BV raised $25 million in a series B financing round for its Excimer Laser Assisted Non-Occlusive Anastomosis heart bypass system. The funds will go towards clinical trials and regulatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback